Generation and functional characterization of MDSC-like cells

OncoImmunology

Volumn 6, Issue 4, 2017, Pages

  Heine, Annkristin ^a   Held, Stefanie Andrea Erika ^a   Schulte Schrepping, Jonas ^b   Wolff, Julia Friederike Andrea ^a   Klee, Kathrin ^b   Ulas, Thomas ^b   Schmacke, Niklas Arndt ^b   Daecke, Solveig Nora ^a   Riethausen, Kati ^a   Schultze, Joachim L ^b,c   Brossart, Peter ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

APC; GITR; IL 10; immunosuppression; MDSC; osteoactivin; PD 1; PD L1; syndecan 4

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROGRAMMED DEATH 1 RECEPTOR; RANTES; TOLL LIKE RECEPTOR; TRANSCRIPTOME; TUMOR NECROSIS FACTOR;

ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ONTOLOGY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MULTIPLEX POLYMERASE CHAIN REACTION; MYELOID-DERIVED SUPPRESSOR CELL; PHENOTYPE; PROTEIN EXPRESSION; RNA SEQUENCE; TRANSCRIPTOMICS; UPREGULATION;

EID: 85017150421     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2017.1295203     Document Type: Article

References (40)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Ann Rev Immunol 2000; 18:767-811; PMID:10837075; http://dx.doi.org/10.1146/annurev.immunol.18.1.767
2. Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat Rev Immunol 2010; 10:403-14; PMID:20498667; http://dx.doi.org/10.1038/nri2780
3. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010; 22:238-44; PMID:20171075; http://dx.doi.org/10.1016/j.coi.2010.01.021
4. Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T, Epstein AL. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med 2011; 9:90; PMID:21658270; http://dx.doi.org/10.1186/1479-5876-9-90
5. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Adv Exp Med Biol 2007; 601:213-23; PMID:17713008
6. Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res 2008; 68:2561-3; PMID:18413722; http://dx.doi.org/10.1158/0008-5472.CAN-07-6229
7. Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer:therapeutic, predictive, and prognostic implications. Semin Oncol 2014; 41:174-84; PMID:24787291; http://dx.doi.org/10.1053/j.seminoncol.2014.02.003
8. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Euro J Immunol 1998; 28:359-69; PMID:9485215; http://dx.doi.org/10.1002/(SICI)1521-4141(199801)28:01%3c359::AID-IMMU359%3e3.0.CO;2-4
9. Knodler A, Schmidt SM, Bringmann A, Weck MM, Brauer KM, Holderried TA, Heine AK, Grünebach F, Brossart P. Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells. Leukemia 2009; 23:535-44; PMID:19005481; http://dx.doi.org/10.1038/leu.2008.301
10. Wirths S, Reichert J, Grunebach F, Brossart P. Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. Cancer Res 2002; 62:5065-8; PMID:12208762
11. Bringmann A, Schmidt SM, Weck MM, Brauer KM, von Schwarzenberg K, Werth D, Grünebach F, Brossart P. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia 2007; 21:732-8; PMID:17301819; http://dx.doi.org/10.1038/sj.leu.2404556
12. Brossart P, Zobywalski A, Grunebach F, Behnke L, Stuhler G, Reichardt VL, Kanz L, Brugger W. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res 2000; 60:4485-92; PMID:10969796
13. Hoppstadter J, Kessler SM, Bruscoli S, Huwer H, Riccardi C, Kiemer AK. Glucocorticoid-induced leucine zipper:a critical factor in macrophage endotoxin tolerance. J Immunol 2015; 194:6057-67; http://dx.doi.org/10.4049/jimmunol.1403207
14. Condamine T, Le Texier L, Howie D, Lavault A, Hill M, Halary F, Cobbold S, Waldmann H, Cuturi MC, Chiffoleau E. Tmem176B and Tmem176A are associated with the immature state of dendritic cells. J Leukoc Biol 2010; 88:507-15; PMID:20501748; http://dx.doi.org/10.1189/jlb.1109738
15. Sharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B, et al. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem 2012; 287:42352-60; PMID:23074222; http://dx.doi.org/10.1074/jbc.M112.400721
16. Baltz KM, Krusch M, Baessler T, Schmiedel BJ, Bringmann A, Brossart P, Salih HR. Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivity. Blood 2008; 112:3735-43; PMID:18689545; http://dx.doi.org/10.1182/blood-2008-03-143016
17. Baltz KM, Krusch M, Bringmann A, Brossart P, Mayer F, Kloss M, Baessler T, Kumbier I, Peterfi A, Kupka S, et al. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans:NK cell/tumor cell interactions. FASEB J 2007; 21:2442-54; PMID:17360848; http://dx.doi.org/10.1096/fj.06-7724com
18. Chung JS, Cruz PD, Jr, Ariizumi K. Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity. Euro J Immunol 2011; 41:1794-9; PMID:21469128; http://dx.doi.org/10.1002/eji.201041233
19. Chung JS, Dougherty I, Cruz PD, Jr, Ariizumi K. Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol 2007; 179:5778-84; PMID:17947650; http://dx.doi.org/10.4049/jimmunol.179.9.5778
20. Chung JS, Tamura K, Akiyoshi H, Cruz PD, Jr, Ariizumi K. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells. J Immunol 2014; 192:2576-84; PMID:24516197; http://dx.doi.org/10.4049/jimmunol.1301857
21. Chung JS, Tomihari M, Tamura K, Kojima T, Cruz PD, Jr, Ariizumi K. The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease. Immunology 2013; 138:173-82; PMID:23113638; http://dx.doi.org/10.1111/imm.12027
22. Chung JS, Yudate T, Tomihari M, Akiyoshi H, Cruz PD, Jr., Ariizumi K. Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function. J Immunol 2009; 183:5190-8; PMID:19794069; http://dx.doi.org/10.4049/jimmunol.0901319
23. Chung MC, Jorgensen SC, Popova TG, Bailey CL, Popov SG. Neutrophil elastase and syndecan shedding contribute to antithrombin depletion in murine anthrax. FEMS Immunol Med Microbiol 2008; 54:309-18; PMID:19049643; http://dx.doi.org/10.1111/j.1574-695X.2008.00480.x
24. Albeituni SH, Ding C, Liu M, Hu X, Luo F, Kloecker G, Bousamra M, 2nd, Zhang HG, Yan J. Yeast-Derived Particulate beta-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer. J Immunol 2016; 196:2167-80; PMID:26810222; http://dx.doi.org/10.4049/jimmunol.1501853
25. Albeituni SH, Yan J. The effects of beta-glucans on dendritic cells and implications for cancer therapy. Anticancer Agents Med Chem 2013; 13:689-98; PMID:23092290; http://dx.doi.org/10.2174/1871520611313050003
26. Tian J, Ma J, Ma K, Guo H, Baidoo SE, Zhang Y, Yan J, Lu L, Xu H, Wang S. beta-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Euro J Immunol 2013; 43:1220-30; PMID:23424024; http://dx.doi.org/10.1002/eji.201242841
27. Kock G, Bringmann A, Held SA, Daecke S, Heine A, Brossart P. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone. Blood 2011; 117:3569-74; PMID:21296999; http://dx.doi.org/10.1182/blood-2010-08-302224
28. Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Grunebach F, Brossart P. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2008; 111:4264-72; PMID:17698636; http://dx.doi.org/10.1182/blood-2006-10-051375
29. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014; 40:274-88; PMID:24530056; http://dx.doi.org/10.1016/j.immuni.2014.01.006
30. Ginhoux F, Schultze JL, Murray PJ, Ochando J, Biswas SK. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol 2016; 17:34-40; PMID:26681460; http://dx.doi.org/10.1038/ni.3324
31. Safadi FF, Xu J, Smock SL, Rico MC, Owen TA, Popoff SN. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 2001; 84:12-26; PMID:11746512; http://dx.doi.org/10.1002/jcb.1259
32. Shikano S, Bonkobara M, Zukas PK, Ariizumi K. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Biol Chem 2001; 276:8125-34; PMID:11114299; http://dx.doi.org/10.1074/jbc.M008539200
33. Tomihari M, Hwang SH, Chung JS, Cruz PD, Jr, Ariizumi K. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion. Exp Dermatol 2009; 18:586-95; PMID:19320736; http://dx.doi.org/10.1111/j.1600-0625.2008.00830.x
34. Schwarzbich MA, Gutknecht M, Salih J, Salih HR, Brossart P, Rittig SM, Grünebach F. The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitors. Cancer Immunol Immunother 2012; 61:193-202; PMID:21874302; http://dx.doi.org/10.1007/s00262-011-1096-1
35. Callahan MK, Postow MA, Wolchok JD. Targeting T cell co-receptors for cancer therapy. Immunity 2016; 44:1069-78; PMID:27192570; http://dx.doi.org/10.1016/j.immuni.2016.04.023
36. Heine A, Held SA, Daecke SN, Riethausen K, Kotthoff P, Flores C, Kurts C, Brossart P. The VEGF-receptor inhibitor axitinib impairs dendritic cell phenotype and function. PloS One 2015; 10:e0128897; PMID:26042424; http://dx.doi.org/10.1371/journal.pone.0128897
37. Heine A, Held SA, Daecke SN, Wallner S, Yajnanarayana SP, Kurts C, Wolf D, Brossart P. The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood 2013; 122:1192-202; PMID:23770777; http://dx.doi.org/10.1182/blood-2013-03-484642
38. Kim D, Langmead B, Salzberg SL. HISAT:a fast spliced aligner with low memory requirements. Nat Methods 2015; 12:357-60; PMID:25751142; http://dx.doi.org/10.1038/nmeth.3317
39. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15:550; PMID:25516281; http://dx.doi.org/10.1186/s13059-014-0550-8
40. Theocharidis A, van Dongen S, Enright AJ, Freeman TC. Network visualization and analysis of gene expression data using BioLayout Express(3D). Nat Protoc 2009; 4:1535-50; PMID:19798086; http://dx.doi.org/10.1038/nprot.2009.177